Venus Remedies Ltd. said its board had recommended a dividend of 30 percent or Rs.3.00 per equity share of Rs.10 each for the fiscal year 2013.
The board also approved raising of funds up to $30 million by way of equity/convertible instruments in the company/its wholly-owned subsidiary, on a preferential basis, subject to approval of the shareholders, statutory approvals, applicable laws, guidelines and regulations.
At the BSE, Venus Remedies shares are currently trading at Rs.334.50, up 0.69 percent from the previous close.
For comments and feedback: editorial@rttnews.com